Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Valent

Showing results (331-340 of 662) with videos related to

Pageof 67
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2007
Genetic engineering of the major timothy grass pollen allergen, Phl p 6, to reduce allergenic activity and preserve immunogenicitySusanne Vrtala, Margarete Focke, Jolanta Kopec, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2009
A combination vaccine for allergy and rhinovirus infections based on rhinovirus-derived surface protein VP1 and a nonallergenic peptide of the major timothy grass pollen allergen Phl p 1Johanna Edlmayr, Katarzyna Niespodziana, Birgit Linhart, et al.
Cells|June 24, 2020
Targeting Nuclear NOTCH2 by Gliotoxin Recovers a Tumor-Suppressor NOTCH3 Activity in CLLRainer Hubmann, Susanne Schnabl, Mohammad Araghi, et al.
Wiener Klinische Wochenschrift|January 1, 2009
Diagnostic algorithms, monitoring, prognostication, and therapy in chronic myeloid leukemia (CML): a proposal of the Austrian CML platformPeter Valent, Thomas Lion, Dominik Wolf, et al.
Leukemia & Lymphoma|January 7, 2006
Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the bone marrow in patients with myelodysplastic syndromes: correlation between VEGF expression and the FAB categoryFriedrich Wimazal, Maria-Theresa Krauth, Anja Vales, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2014
Identification of campath-1 (CD52) as novel drug target in neoplastic stem cells in 5q-patients with MDS and AMLKatharina Blatt, Harald Herrmann, Gregor Hoermann, et al.
Journal of Cellular and Molecular Medicine|March 1, 2022
JAK-STAT core cancer pathway: An integrative cancer interactome analysisFettah Erdogan, Tudor Bogdan Radu, Anna Orlova, et al.
Cells|January 22, 2024
Coronavirus Receptor Expression Profiles in Human Mast Cells, Basophils, and EosinophilsLina Degenfeld-Schonburg, Irina Sadovnik, Dubravka Smiljkovic, et al.
Blood|August 28, 2007
Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targetsUwe Rix, Oliver Hantschel, Gerhard Dürnberger, et al.
The American Journal of Pathology|November 7, 2009
Expression of activated STAT5 in neoplastic mast cells in systemic mastocytosis: subcellular distribution and role of the transforming oncoprotein KIT D816VChristian Baumgartner, Sabine Cerny-Reiterer, Karoline Sonneck, et al.
Pageof 67

Showing results (331-340 of 662) with videos related to

Sort By:
Pageof 67
Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2007
Genetic engineering of the major timothy grass pollen allergen, Phl p 6, to reduce allergenic activity and preserve immunogenicitySusanne Vrtala, Margarete Focke, Jolanta Kopec, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2009
A combination vaccine for allergy and rhinovirus infections based on rhinovirus-derived surface protein VP1 and a nonallergenic peptide of the major timothy grass pollen allergen Phl p 1Johanna Edlmayr, Katarzyna Niespodziana, Birgit Linhart, et al.
Cells|June 24, 2020
Targeting Nuclear NOTCH2 by Gliotoxin Recovers a Tumor-Suppressor NOTCH3 Activity in CLLRainer Hubmann, Susanne Schnabl, Mohammad Araghi, et al.
Wiener Klinische Wochenschrift|January 1, 2009
Diagnostic algorithms, monitoring, prognostication, and therapy in chronic myeloid leukemia (CML): a proposal of the Austrian CML platformPeter Valent, Thomas Lion, Dominik Wolf, et al.
Leukemia & Lymphoma|January 7, 2006
Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the bone marrow in patients with myelodysplastic syndromes: correlation between VEGF expression and the FAB categoryFriedrich Wimazal, Maria-Theresa Krauth, Anja Vales, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2014
Identification of campath-1 (CD52) as novel drug target in neoplastic stem cells in 5q-patients with MDS and AMLKatharina Blatt, Harald Herrmann, Gregor Hoermann, et al.
Journal of Cellular and Molecular Medicine|March 1, 2022
JAK-STAT core cancer pathway: An integrative cancer interactome analysisFettah Erdogan, Tudor Bogdan Radu, Anna Orlova, et al.
Cells|January 22, 2024
Coronavirus Receptor Expression Profiles in Human Mast Cells, Basophils, and EosinophilsLina Degenfeld-Schonburg, Irina Sadovnik, Dubravka Smiljkovic, et al.
Blood|August 28, 2007
Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targetsUwe Rix, Oliver Hantschel, Gerhard Dürnberger, et al.
The American Journal of Pathology|November 7, 2009
Expression of activated STAT5 in neoplastic mast cells in systemic mastocytosis: subcellular distribution and role of the transforming oncoprotein KIT D816VChristian Baumgartner, Sabine Cerny-Reiterer, Karoline Sonneck, et al.
Pageof 67